Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation”

3 trials

Showing 3 of 3 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04856982
What this trial is testing

BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation

Who this might be right for
Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation
Biogen 158
Post-approval studies (Phase 4)Looking for participantsNCT07223723
What this trial is testing

Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese Participants With SOD-1 Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Biogen 12
Not applicableApproved For MarketingNCT04972487
What this trial is testing

Expanded Access Program for Tofersen in Participants With Superoxide Dismutase 1-Amyotropic Lateral Sclerosis

Who this might be right for
Superoxide Dismutase 1-Amyotropic Lateral Sclerosis
Biogen

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation